|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
$2,360
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
$1,200
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
$2,513
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
$4,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
$5,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$52,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$50,488
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$1,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$2,042
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Viruses and Cancer
|
2T32CA060395-21A1
|
$224,723
|
$56,181
|
MEYERS, CRAIG
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
|
Virus-targeted therapeutic for EBV-Associated Malignancies
|
5R44CA153474-03
|
$519,583
|
$519,583
|
PERRINE, SUSAN
|
PHOENICIA BIOSCIENCES, INC.
|
|
|
Viral Oncology Training Grant
|
3T32CA009111-38S1
|
$13,628
|
$4,088
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
|
Viral Oncology Training Grant
|
5T32CA009111-39
|
$387,094
|
$116,128
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$11,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$2,859
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$385,965
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-42S1
|
$59,999
|
$11,400
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
$1,190,063
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
$54,399
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
|
1U54CA221208-01
|
$731,876
|
$343,982
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
Training in Tumor Virology
|
2T32CA115299-11
|
$369,654
|
$147,862
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Training In Tumor Virology
|
3T32CA115299-10S1
|
$3,684
|
$1,474
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
|
5R42CA153845-03
|
$772,615
|
$772,615
|
SAMPSON, JOHN
|
ANNIAS IMMUNOTHERAPEUTICS, INC.
|
|
|
The Zambia AIDS Malignancies Diagnosis and Pathogenesis Program (ZAMDAPP)
|
1U54CA221204-01
|
$670,280
|
$113,948
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
|
The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis
|
5R00CA175181-04
|
$249,000
|
$249,000
|
SKALSKY, REBECCA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma
|
5R01CA184283-04
|
$424,977
|
$212,489
|
COBBS, CHARLES
|
SWEDISH MEDICAL CENTER, FIRST HILL
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S1
|
$204,369
|
$8,175
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S2
|
$57,797
|
$2,312
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S3
|
$79,482
|
$3,179
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$194,626
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The effect of statins on B cell dysfunction in HIV infection
|
5R21CA200420-02
|
$215,985
|
$215,985
|
MARTINEZ-MAZA, OTONIEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Targeting KSHV malignancies and persistent infection
|
5R01CA197153-03
|
$377,438
|
$377,438
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
5R01CA163217-07
|
$342,759
|
$171,380
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Studying the role of KSHV-encoded miRNAs
|
5R01CA119917-10
|
$301,913
|
$301,913
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$924,476
|
$832,028
|
Yarchoan, Robert
|
CCR (NCI)
|
|
|
Studies on drug resistance in HIV-related Kaposi's sarcoma
|
ZIA BC 011730
|
$83,962
|
$83,962
|
Gottesman, Michael
|
CCR (NCI)
|
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-16
|
$384,750
|
$384,750
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
SPORE in Lymphoma
|
2P50CA126752-11
|
$3,097,657
|
$371,719
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
5R01CA170023-05
|
$393,163
|
$393,163
|
Zhao, Bo
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Role of KSHV viral proteins in signaling and pathogenesis
|
5R01CA096500-15
|
$281,108
|
$281,108
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Role of B cells in murine gammaherpesvirus 68
|
5R01CA095318-13
|
$368,305
|
$368,305
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
5R01CA075922-21
|
$794,238
|
$794,238
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
Regulation of KSHV infection and replication by MAPK pathways
|
5R01CA124332-11
|
$304,095
|
$304,095
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Regulation of EBV Latency by EBNA1
|
5R01CA093606-15
|
$329,956
|
$329,956
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
|
Regional Oncology Research Center
|
2P30CA006973-54
|
$7,060,038
|
$141,201
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Regional Oncology Research Center
|
3P30CA006973-54S1
|
$125,000
|
$2,500
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Regional Oncology Research Center
|
3P30CA006973-54S2
|
$60,000
|
$1,200
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Regional Oncology Research Center
|
3P30CA006973-54S3
|
$25,000
|
$500
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
5R44CA192859-03
|
$866,508
|
$866,508
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
|
Reactivation of Kaposi's Sarcoma-Associated Herpesvirus
|
5R01CA091791-15
|
$284,547
|
$284,547
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Total relevant funding to Herpes - Other for this search: $50,074,340
|
